Welcome to our dedicated page for National Resh news (Ticker: NRC), a resource for investors and traders seeking the latest updates and insights on National Resh stock.
National Research Corporation Common Stock (Delaware) (symbol: NRC) is dedicated to enhancing the experiences of patients, residents, and healthcare providers for over 35 years. Operating primarily in the United States and Canada, NRC Health provides analytics and insights that help healthcare organizations measure and improve patient and employee experiences, fostering greater engagement and loyalty.
NRC Health's offerings include a wide range of solutions that deliver value to its clients by enabling a deeper understanding of the individuals they serve. This holistic approach includes proprietary methods and tools that aid healthcare systems in designing experiences that build trust and inspire loyalty. These solutions are critical for healthcare providers, payers, and other organizations aiming to improve care delivery and patient outcomes.
In recent developments, NRC Health has partnered with LifeBridge Health, one of Maryland’s largest health systems, to implement the Human Understanding® program. This partnership, highlighted by NRC Health’s comprehensive data-driven insights and personalized healthcare solutions, aims to enhance patient care and satisfaction through innovative, human-centered approaches. The collaboration also involves administering the Consumer Assessment of Healthcare Providers and Systems (CAHPS) survey to ensure consistent quality measures.
Financially, NRC Health remains robust, drawing significant revenue from its United States operations. Its focused market research, patient-centered initiatives, and consumer preference data have earned NRC Health a top ranking for Patient Experience Improvement in the 2023 Best in KLAS report.
For more information about NRC Health, their services, or recent updates, visit www.nrchealth.com. You can also contact them at 800-388-4264 or via email at info@nrchealth.com.
National Research Corporation reported strong Q2 2021 results, achieving a 17% revenue increase to $36.4 million and a 32% rise in operating income to $12.2 million. The total recurring contract value grew 5% to $149.8 million, driven by a 29% boost in Voice of the Customer offerings. The cash balance increased to $48.9 million. However, the effective tax rate rose to 25% from 10% in the previous year, impacting net income which reached $8.9 million, up from $7.7 million. The company focuses on organic growth and enhancing client relationships.
National Research Corporation (NASDAQ:NRC) declared a quarterly cash dividend of $0.12 per share, payable July 15, 2021. Shareholders on record by June 30, 2021 will receive this dividend. With over 40 years of experience, NRC remains a leading provider of analytics and insights aimed at enhancing human understanding.
NRC Health enhances its leadership with the appointment of Penny Wheeler, CEO of Allina Health, and Stephen Lockhart, former Chief Medical Officer of Sutter Health, to its Board of Directors, effective immediately. These seasoned executives bring extensive healthcare experience and a commitment to patient-centered care. CEO Michael Hays emphasized their potential to advance NRC Health's mission of 'Human Understanding' in healthcare. Wheeler and Lockhart expressed enthusiasm for contributing to NRC’s vision of personalized healthcare experiences, particularly for underserved communities.
National Research Corporation (NASDAQ: NRC) reported its Q1 2021 results, highlighting a 5% revenue increase to $35.5 million and a 7% rise in operating income to $12 million compared to Q1 2020. The company achieved a 19% growth in Voice of the Customer offerings and secured new clients such as Wake Forest Baptist Health. However, net income dropped to $9.2 million from $11.8 million year-over-year, leading to a decrease in diluted earnings per share from $0.46 to $0.36. Total operating expenses increased by 3% to $23.4 million, with notable rises in selling, general and administrative expenses.
National Research Corporation (NASDAQ:NRC) has declared a quarterly cash dividend of $0.12 per share, scheduled for payment on April 27, 2021. Shareholders of record as of the close of business on April 19, 2021 will be eligible to receive this dividend. This announcement highlights NRC's commitment to returning value to its investors, sustaining a tradition of over 40 years in providing analytics and insights aimed at improving human understanding.
NRC Health has released the 2021 Healthcare Consumer Trends Report: Pediatrics, analyzing data on pediatric healthcare consumers during the COVID-19 pandemic. The report highlights shifts in brand loyalty, telehealth adoption, and parental preferences in provider selection. Key findings include a 2.2% decline in pediatric brand preference, with quality being the main factor for provider choice among 52% of parents. Furthermore, 51% of parents utilized telehealth services, and 80% expressed interest in discussions about wearable tech data with healthcare providers.
FAQ
What is the current stock price of National Resh (NRC)?
What is the market cap of National Resh (NRC)?
What services does NRC Health provide?
Where does NRC Health operate?
What is the Human Understanding® program?
Who are NRC Health's recent partners?
What is the CAHPS survey?
How long has NRC Health been in operation?
What distinguishes NRC Health in the market?
How can I contact NRC Health?
What type of organizations benefit from NRC Health's services?
How does NRC Health support healthcare organizations?
